Join Laura Peters, NP, and Meg Fraser, NP, for a discussion of the latest AAHFN scientific statement, developed jointly with the Heart Failure Society of America, on integrative health technologies in heart failure care. The hosts will discuss practical guidance on incorporating digital health tools into heart failure care—shifting from singular devices to coordinated, team-based, and actionable systems of care.

A conversation with Chris Bell, Robin Miller, and Linda Ordway about the future of the AAHFN.

Tune in for the top 10 takeaways from the AAHFN 2026 Annual Meeting.

Join Laura Peters, NP and Meg Fraser, NP for a discussion of the latest AAHFN scientific statement, developed jointly with the Heart Failure Society of America, on integrative health technologies in heart failure care. The hosts will discuss practical guidance on incorporating digital health tools into heart failure care—shifting from singular devices to coordinated, team-based, and actionable systems of care.

Chris interviews Melissa Fix, BSN, is the program manager for temporary mechanical circulatory support (MCS) at Keck Medical Center, University of Southern California. She specializes in the care of patients with advanced heart failure, cardiogenic shock, and complex cardiothoracic surgical needs, with a particular focus on advancing a nurse-led ECMO model. This episode was made possible through grant funding from Abbott.

Chris bell interviews Michael Arnold DNP, FHRS, about what is new in CCM therapy and when GDMT is not enough.

Join us for a conversation with a heart failure nurse leader who’s been at the forefront of remote monitoring. In this episode, we explore the clinical value of CardioMEMS in managing heart failure, especially for patients who appear stable but are at high risk for decompensation—along with insights on the expanded National Coverage Determination and the future of cardiovascular care.

A review of UltraFiltration as a therapeutic modality to overcome chronically decompensated heart failure in patients who struggle poorly responsive to diuretics. A brief review of pivotal trials as well as discussion of real-world experience with the therapy in a successful advanced heart failure clinic.